The actomyosin complex is the major cytoskeletal component that controls ce
ll contraction. In this study, we investigated the effects of actomyosin in
teraction on endothelial barrier function and gap formation. Activated myos
in light chain kinase (MLCK) protein was transferred into coronary venular
endothelial cell (CVEC) monolayers. Uptake of the activated protein resulte
d in a significant shift in myosin light chain (MLC) from an unphosphorylat
ed to a diphosphorylated form. In addition, MLCK induced a hyperpermeabilit
y response of the monolayer as measured by albumin transendothelial flux. M
icroscopic examination of MLCK-treated CVECs revealed widespread gap format
ion in the monolayer, loss of peripheral beta-catenin, and increases in act
in stress fibers. Inhibition of all of the above responses by a specific ML
CK inhibitor suggests they are the direct result of exogenously added MLCK.
These data suggest that activation of MLCK in CVECs causes phosphorylation
of MLC and contraction of CVECs, resulting in gap formation and concomitan
t increases in permeability. This study uses a novel technique to measure t
he effects of an activated kinase on both its substrate and cellular morpho
logy and function through direct transference into endothelial cells.